How many total Epilepsy Treatment Devices companies are there?

As of Apr 2026, there are 20 active companies in Epilepsy Treatment Devices sector.

Which countries have the most Epilepsy Treatment Devices companies?

United States (9) has the highest number of Epilepsy Treatment Devices companies, followed by Israel (4) and Germany (3).

How many Epilepsy Treatment Devices companies are funded?

As of Apr 2026, 17 companies in this sector have received funding.

Which company has raised the most funding in Epilepsy Treatment Devices sector?

As of Apr 2026, Cadence Neuroscience has secured $41M in funding, making it the highest-funded company in the Epilepsy Treatment Devices sector.

Which country has attracted the most investment in Epilepsy Treatment Devices companies?

With $151M in total funding, United States has attracted the most investment among Epilepsy Treatment Devices companies.

Who are the top investors in Epilepsy Treatment Devices companies?

The top investors in Epilepsy Treatment Devices companies by number of investments are Europa, InterWest Partners and JAZZ Venture Partners

How much venture capital has Epilepsy Treatment Devices sector attracted?

In the last 10 years, venture capital firms have invested $134M in this sector.

Epilepsy Treatment Devices - 2026 Market & Investments Trends

The Epilepsy Treatment Devices comprises 24 companies, including 17 funded companies having collectively raised $365M in venture capital money and private equity. Out of these, 8 are Series A+ funded.

Epilepsy Treatment Devices sector has seen 1 acquisition and 4 IPOs. This represents almost 20.8% of all such companies - which is higher than the 4.9% exit rate of tech companies in general.

This sector includes companies developing therapeutic devices for the treatment of Seizures and Epilepsy.

Key Metrics

Total Companies

Top Companies

NeuroPace, LivaNova & more

Total Funding

$365M

Funded Companies

Series A+ Companies

Series C+ Companies

IPOs

Acquisitions

View complete details of this sector

There are more than 24 companies in Epilepsy Treatment Devices. NeuroPace is the top Epilepsy Treatment Devices company globally, ranked using Tracxn Score (what's this?).

Here are 5 of the top Epilepsy Treatment Devices companies globally:

Company	Description	Location	Founded	Current Stage	Private Funding Raised
NeuroPace	Developer of implantable neurostimulation system for epilepsy treatment	Mountain View (United States)	1997	Public	$264M
LivaNova	Provider of cardiac and neurological therapeutic devices	London (United Kingdom)	2015	Public	-
Cyberonics	Vagus nerve stimulation device for epilepsy and treatment resistant depression	Houston (United States)	1987	Public	-
Engage Therapeutics	Inhaled drug-device combo as rescue treatment for uncontrolled epileptic seizures	Summit (United States)	2017	Acquired	$30.6M
Cadence Neuroscience	Developer of medical devices for treating neurological disorders	Redmond (United States)	2016	Series B	$41M

Get a longer list of companies

Companies founded year-on-year in Epilepsy Treatment Devices

2 Epilepsy Treatment Devices startups were founded in 2021 - this is the most number of startups founded in any year in the last 10 years.

Total Number of Companies

Year	No. of companies
2026	-
2025	-
2024	-
2023	-
2022	1
2021	2
2020	2
2019	2
2018	-
2017	1

Companies founded across countries in Epilepsy Treatment Devices

United States has 9 Epilepsy Treatment Devices startups, the most by any country, followed by Israel which has 4 startups and Germany which has 3.

Total Number of Companies

Country	No. of companies
United States	9
Israel	4
Germany	3
China	1
Australia	1
South Korea	1
United Kingdom	1
Denmark	1
Netherlands	1
Turkey	1

Stage-wise distribution of Epilepsy Treatment Devices

Out of the total 24 Epilepsy Treatment Devices companies, 17 have secured funding. Among them, 8 have reached Series A or higher, and 6 to Series B or beyond.

Founded - 24

Funded - 17

Series A+ - 8

Series B+ - 6

Series C+ - 5

Company Stage	No. of companies
Founded	24
Funded	17
Series A+	8
Series B+	6
Series C+	5

Want to know more about Epilepsy Treatment Devices ? Signup and explore Tracxn for free

20+ Total Companies
$365M+ Total Funding
15+ Funded Companies
4 IPOs

Total funding year-on-year in Epilepsy Treatment Devices

Epilepsy Treatment Devices saw a total funding of more than $254M in the last 10 years. The most amount of funding was in 2016 at more than $74.5M.

Total Funding

Year	Total Funding
2023	$26M
2022	$2.83M
2021	$1.23M
2020	$71.9M
2019	$24.6M
2018	$3.03M
2017	$27.5M

Total funding across countries in Epilepsy Treatment Devices

In the last 10 years, Epilepsy Treatment Devices startups in United States have recieved the highest funding among all countries - $151M. Germany follows with $2.83M and United Kingdom with $1.23M.

Total Funding

Country	Total Funding
United States	$151M
Germany	$2.83M
United Kingdom	$1.23M
Netherlands	$110K
Israel	-

Total funding amount raised by stage in Epilepsy Treatment Devices

Over the last 10 years, Epilepsy Treatment Devices have seen $1.53M into Seed Stage funding rounds, $71.6M into Early Stage funding rounds and $69.4M go into Late Stage funding rounds.

Funding Stage	Total Funding
Early Stage	$71.6M
Late Stage	$69.4M
Post IPO	$8.92M
Grant	$4.17M
Seed Stage	$1.53M

Recent Funding Rounds in Epilepsy Treatment Devices

In the year 2023, till February 2023, Epilepsy Treatment Devices companies have raised $26M in equity funding across 1 round.

Here are some recent, important funding rounds in Epilepsy Treatment Devices:

Company	Round Raised	Amount Raised	Funding Date	Investors
Cadence Neuroscience	Series B	7523	Feb 28, 2023	F-Prime Capital and 6 more
Squalus Medical	Seed	7690	Jun 15, 2022	Innovation Pharmaceuticals
NeuroPace	Series E	3211	Aug 19, 2020	Accelmed and 3 more
Engage Therapeutics	Series A	4451	Oct 29, 2019	-
Cadence Neuroscience	Series A	9126	Oct 11, 2019	JAZZ Venture Partners and 1 more

See a more detailed list of funding rounds

Europa is the top investor in Epilepsy Treatment Devices companies based on number of companies invested.

Here are some top investors in Epilepsy Treatment Devices:

Investor	Location	Top Portfolio Companies
Europa	Belgium	LivaNova and NightWatch
InterWest Partners	Los Altos (United States)	NeuroPace
JAZZ Venture Partners	San Francisco (United States)	Cadence Neuroscience
National Oceanic and Atmospheric Administration	Washington, DC (United States)	NeuroPace
Domain Associates	Princeton (United States)	NeuroPace

See a more detailed list of investors

In the year 2020, till June 2020, 1 acquisition happened in Epilepsy Treatment Devices.

Here are some recent, important acquisitions in Epilepsy Treatment Devices:

Company	Acquisition Type	Acquisition Date	Acquirers
Engage Therapeutics	Business Acquisition	Jun 05, 2020	UCB

See a more detailed list of acquisitions

Acquisition trends in Epilepsy Treatment Devices

Here are the acquisition trends in Epilepsy Treatment Devices:

Total Number of Acquisitions

Year	No. of companies
2026	-
2025	-
2024	-
2023	-
2022	-
2021	-
2020	1
2019	-
2018	-
2017	-

In the year 2025, till January 2025, 1 IPO happened in Epilepsy Treatment Devices.

Here are some recent, important IPOs in Epilepsy Treatment Devices:

Company	IPO Date	Exchange Symbol
OceansBIo	Jan 14, 2025	Korea Exchange (KRX)
NeuroPace	Apr 22, 2021	National Association of Securities Dealers Automated Quotations (NASDAQ)
NeuroOne	Aug 04, 2017	OTC Markets (OTCMKTS)
Cyberonics	Feb 19, 1993	National Association of Securities Dealers Automated Quotations (NASDAQ)
LivaNova	Feb 10, 1993	National Association of Securities Dealers Automated Quotations (NASDAQ)